Publications (original articles or review articles) published in 2019 from OUS - Rheumatology Research Group
29 publications found
Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers
Arthritis Res Ther, 21 (1), 181
DOI 10.1186/s13075-019-1961-4, PubMed 31366407
Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium to Longstanding Juvenile Dermatomyositis
Arthritis Care Res (Hoboken), 71 (4), 492-497
DOI 10.1002/acr.23687, PubMed 29953739
Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active/inactive disease
Rheumatology (Oxford), 58 (3), 492-501
DOI 10.1093/rheumatology/key342, PubMed 30508195
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
J Clin Med, 8 (11)
DOI 10.3390/jcm8112013, PubMed 31752231
Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations
Sci Rep, 9 (1), 7319
DOI 10.1038/s41598-019-43714-5, PubMed 31086200
Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions
Nat Med, 25 (5), 734-737
DOI 10.1038/s41591-019-0403-9, PubMed 30911136
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
Lancet Child Adolesc Health, 3 (4), 255-263
DOI 10.1016/S2352-4642(19)30027-6, PubMed 30819662
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease
Expert Rev Clin Immunol, 15 (10), 1009-1017
DOI 10.1080/1744666X.2020.1668269, PubMed 31566449
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Ann Rheum Dis, 78 (7), 979-987
DOI 10.1136/annrheumdis-2018-214816, PubMed 30967395
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Arthritis Rheumatol, 71 (6), 972-982
DOI 10.1002/art.40815, PubMed 30624031
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
Rheumatology (Oxford), 58 (2), 313-320
DOI 10.1093/rheumatology/key285, PubMed 30281089
Juvenile Sjögren's Syndrome: Clinical Characteristics With Focus on Salivary Gland Ultrasonography
Arthritis Care Res (Hoboken), 72 (1), 78-87
DOI 10.1002/acr.23839, PubMed 30697959
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
RMD Open, 5 (1), e000826
DOI 10.1136/rmdopen-2018-000826, PubMed 30997150
Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches
J Scleroderma Relat Disord, 6 (1), 37-43
DOI 10.1177/2397198319891282, PubMed 35382247
Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
EBioMedicine, 50, 379-386
DOI 10.1016/j.ebiom.2019.10.050, PubMed 31732480
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
PLoS One, 14 (7), e0220079
DOI 10.1371/journal.pone.0220079, PubMed 31335881
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nat Commun, 10 (1), 4955
DOI 10.1038/s41467-019-12760-y, PubMed 31672989
Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort
Lupus, 28 (7), 818-825
DOI 10.1177/0961203319847275, PubMed 31072277
Physical Fitness in Patients With Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis Diagnosed in the Era of Biologics: A Controlled Cross-Sectional Study
Arthritis Care Res (Hoboken), 71 (12), 1611-1620
DOI 10.1002/acr.23818, PubMed 30474929
Measurement properties and performance of an eight-minute submaximal treadmill test in patients with juvenile idiopathic arthritis: a controlled study
Pediatr Rheumatol Online J, 17 (1), 14
DOI 10.1186/s12969-019-0316-7, PubMed 30961626
Distorted Taste and Impaired Oral Health in Patients with Sicca Complaints
Nutrients, 11 (2)
DOI 10.3390/nu11020264, PubMed 30682880
Preclinical Carotid Atherosclerosis in Patients With Juvenile-Onset Mixed Connective Tissue Disease
J Stroke Cerebrovasc Dis, 28 (5), 1295-1301
DOI 10.1016/j.jstrokecerebrovasdis.2019.01.027, PubMed 30772156
Increased Endothelial Activation in Patients with Mixed Connective Tissue Disease
J Stroke Cerebrovasc Dis, 29 (2), 104563
DOI 10.1016/j.jstrokecerebrovasdis.2019.104563, PubMed 31831329
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
ACR Open Rheumatol, 1 (4), 258-266
DOI 10.1002/acr2.1037, PubMed 31777802
Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis
J Rheumatol, 46 (10), 1335-1344
DOI 10.3899/jrheum.180948, PubMed 30877211
Gastrointestinal tract microbiota modifications in systemic sclerosis
Eur J Rheumatol, 7 (Suppl 3), S228-S236
DOI 10.5152/eurjrheum.2019.19103, PubMed 31922474
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
J Rheumatol, 46 (10), 1316-1325
DOI 10.3899/jrheum.180441, PubMed 30770517
Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study
J Rheumatol, 46 (7), 739-747
DOI 10.3899/jrheum.180526, PubMed 30877222